13F-HR filed by NOVO HOLDINGS A/S
NOVO HOLDINGS A/S filed this 13F-HR for the quarter ended 2019-12-31, filed 2020-02-14, with 29 holding rows worth $1,552,731,000.
- Accession
- 0000950123-20-002402
- Filer
- CIK 1388325
- Filed
- 2020-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2019
A holdings report, 29 entries on the cover page, a total value of $1,552,731,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,552,731,000 with VALUE read as thousands by filing date, 13F file number 028-16231. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| VTI | 922908769 | COM | 4,325,200 | $707,689,000 | thousands by filing date | |
| INOGEN INC | 45780L104 | COM | 3,549,321 | $242,525,000 | thousands by filing date | |
| CABLE ONE INC | 12685J105 | COM | 63,947 | $95,183,000 | thousands by filing date | |
| Apple Inc | 037833100 | COM | 267,788 | $78,636,000 | thousands by filing date | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 2,445,147 | $59,955,000 | thousands by filing date | |
| MORPHIC HLDG INC | 61775R105 | COM | 2,645,446 | $45,396,000 | thousands by filing date | |
| GALERA THERAPEUTICS EQUICLASS EQUITY | 36338D108 | COMMON STOCK | 3,409,021 | $44,863,000 | thousands by filing date | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 2,434,470 | $38,976,000 | thousands by filing date | |
| BROOKFIELD ASSET MANAGEMENT IN | 112585104 | CL A LTD VT SH | 672,652 | $38,879,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 2,317,870 | $22,576,000 | thousands by filing date | |
| AKEBIA THERAPEUTICS INC | 00972D105 | COMMON STOCK | 3,100,000 | $19,592,000 | thousands by filing date | |
| SI BONE INC | 825704109 | COM | 892,684 | $19,193,000 | thousands by filing date | |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 670,036 | $16,195,000 | thousands by filing date | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 2,927,560 | $15,926,000 | thousands by filing date | |
| SEASPINE HLDGS CORP | 81255T108 | COM | 1,308,037 | $15,710,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 170,667 | $13,672,000 | thousands by filing date | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 175,000 | $12,987,000 | thousands by filing date | |
| ENTASIS THERAPEUTICS HLDGS I | 293614103 | COM | 2,181,843 | $10,844,000 | thousands by filing date | |
| SILK ROAD MEDICAL INC | 82710M100 | COMMON STOCK | 245,000 | $9,893,000 | thousands by filing date | |
| FLEXION THERAPEUTICS INC | 33938JAB2 | NOTE | 450,000 | $9,315,000 | thousands by filing date | |
| SPERO THERAPEUTICS INC | 84833T103 | COM | 931,099 | $8,948,000 | thousands by filing date | |
| INTERSECT ENT INC | 46071F103 | COM | 217,709 | $5,421,000 | thousands by filing date | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 740,740 | $4,259,000 | thousands by filing date | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 135,009 | $3,387,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 479,074 | $3,377,000 | thousands by filing date | |
| NEURONETICS INC | 64131A105 | COM | 736,578 | $3,307,000 | thousands by filing date | |
| MYOKARDIA INC | 62857M105 | COM | 30,348 | $2,212,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 35,900 | $1,954,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 35,700 | $1,861,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-20-002402 | this filing | 2020-02-14 | acceptance time not in the bulk data set |